πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 113 of 200 Β· A–Z by INN

  1. lumasiran

    OXLUMO Lacuna Pharma Pty Ltd

    EMA: approved Β· TGA: approved

    A16AX18

  2. lumasiran sodium

    OXLUMO Alnylam Netherlands B.V.

    SUBCUTANEOUS FDA: approved

  3. lumateperone

    LUMATEPERONE

    FDA: approved

  4. lumateperone tosylate

    LUMATEPERONE TOSYLATE

    ORAL FDA: approved

  5. lurasidone

    APO-LURASIDONE Alphapharm Pty Ltd

    EMA: approved Β· TGA: approved

    N05AE05

  6. lurasidone hydrochloride

    LATUDA Amneal Pharma Europe Ltd

    ORAL FDA: approved

  7. lurbinectedin

    ZEPZELCA Jazz Pharmaceuticals Ireland Limited

    INTRAVENOUS FDA: approved Β· EMA: unknown

    L01XX69

  8. luspatercept

    REBLOZYL

    EMA: approved

    B03XA06

  9. luspatercept-aamt

    REBLOZYL

    SUBCUTANEOUS FDA: approved

  10. lusutrombopag

    MULPLEO (PREVIOUSLY LUSUTROMBOPAG SHIONOGI)

    ORAL FDA: approved Β· EMA: approved Β· PMDA: approved

    B02BX

  11. lutetium (177lu) chloride

    ENDOLUCINBETA

    EMA: approved

    V10X

  12. lutetium (177lu) oxodotreotide

    LUTATHERA

    EMA: approved

    V10XX04

  13. lutetium (177lu) vipivotide tetraxetan

    PLUVICTO

    EMA: approved

    V10XX

  14. lutetium lu 177 dotatate

    LUTATHERA

    INTRAVENOUS FDA: approved

  15. lutetium lu-177 vipivotide tetraxetan

    PLUVICTO

    INTRAVENOUS FDA: approved

  16. lutropin alfa

    LUVERIS Merck KGaA, Darmstadt, Germany

    EMA: approved Β· TGA: approved

    G03GA07

  17. luveris

    NMPA: clinical trials

  18. ly01610 ( irinotecan hydrochloride liposome injection )

    NMPA: clinical trials

  19. ly01610 ( irinotecan hydrochloride liposome injection ) with 5-fu（fluorouracil injectionοΌ‰

    NMPA: clinical trials

  20. ly3209590

    NMPA: clinical trials

  21. ly3484356

    NMPA: clinical trials

  22. ly4395089

    NMPA: clinical trials

  23. lypressin

    DIAPID

    NASAL FDA: approved

  24. lysine + thiamine + pyridoxine + cyanocobalamin + ferric pyrophosphate

    ACCOMIN ADULT TONIC Pfizer Australia Pty Ltd

    TGA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources